EC0489
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for EC0489, covering 2012-08-08 to 2012-08-08. Get the full timeline:
Most recent: Clinical Trial Update: Study of EC0489 for the Treatment of Refractory or Metastatic Tumors [Phase 1]